O. Hentic

发表

Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations

V. Vilgrain, P. Ruszniewski, V. Rebours, 2012, The American Journal of Gastroenterology.

Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors

V. Paradis, P. Bedossa, A. Sauvanet, 2015, Neuroendocrinology.

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.

V. Paradis, P. Bedossa, P. Ruszniewski, 2016, Endocrine-related cancer.

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

E. Raymond, S. Faivre, C. Lombard-Bohas, 2018, Neuroendocrinology.

Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.

P. Chanson, M. Ronot, A. Sauvanet, 2014, JAMA surgery.

Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors.

R. Kianmanesh, O. Hentic, P. Hammel, 2018, Journal of visceral surgery.

FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.

P. Ruszniewski, A. Couvelard, V. Rebours, 2012, Endocrine-related cancer.

CFTR Gene Mutation in Patients with Apparently Idiopathic Pancreatitis: Lack of Phenotype-Genotype Correlation

P. Ruszniewski, V. Rebours, P. Lévy, 2010, Pancreatology.

O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumors.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Does tobacco influence the natural history of autoimmune pancreatitis?

P. Ruszniewski, A. Couvelard, V. Rebours, 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Liver-Directed Therapies in Neuroendocrine Tumors

M. Ronot, V. Vilgrain, P. Ruszniewski, 2014 .

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract

V. Vilgrain, P. Ruszniewski, M. Vullierme, 2012, Targeted Oncology.

Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors.

E. Raymond, P. Bedossa, P. Ruszniewski, 2010, Endocrine-related cancer.

Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database

P. Ruszniewski, P. Lévy, O. Hentic, 2017, European journal of gastroenterology & hepatology.

Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?

E. Raymond, A. Sauvanet, J. Belghiti, 2009, Surgery.

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers

E. Raymond, S. Faivre, C. Dreyer, 2016, Acta oncologica.

Two-step Surgery for Synchronous Bilobar Liver Metastases From Digestive Endocrine Tumors: A Safe Approach for Radical Resection

V. Vilgrain, A. Sauvanet, J. Belghiti, 2008, Annals of surgery.

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors

M. Ducreux, E. Baudin, R. Guimbaud, 2021, Neuroendocrinology.

Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma.

M. Ronot, V. Vilgrain, A. Sauvanet, 2020, Diagnostic and interventional imaging.

Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome

B. Wiedenmann, P. Ruszniewski, M. Pavel, 2011, Cancer.

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis

P. Ruszniewski, R. Kianmanesh, O. Hentic, 2012, Case Reports in Gastroenterology.

Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2010, Endocrine-related cancer.

Somatostatin receptor subtype 2 expression and somatostatin receptor scintigraphy positivity in pancreatic serous cystadenomas.

P. Bedossa, A. Sauvanet, P. Ruszniewski, 2015, Pancreas.

Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors

P. Ruszniewski, O. Hentic, R. Lebtahi, 2020, European Radiology.

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

F. Pilleul, C. Lombard-Bohas, P. Ruszniewski, 2012, Neuroendocrinology.

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)

M. Ducreux, E. Baudin, V. Rohmer, 2017, Neuroendocrinology.

Imaging of Neuroendocrine Tumors and Challenges in Response Evaluation for Targeted Therapies

M. Ronot, V. Vilgrain, E. Raymond, 2014 .

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours

P. Ravaud, P. Rougier, P. Ruszniewski, 2006, British Journal of Cancer.

Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.

A. Sauvanet, A. Couvelard, V. Rebours, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.

R. Kianmanesh, O. Hentic, P. Hammel, 2018, Journal of visceral surgery.

Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors

V. Paradis, P. Bedossa, A. Sauvanet, 2015, Neuroendocrinology.

Advances with Somatostatin Analogs in Neuroendocrine Tumors; The Promise of Radionuclides in Neuroendocrine Tumors

E. Raymond, P. Ruszniewski, O. Hentic, 2014 .

Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors

C. Lombard-Bohas, P. Ruszniewski, A. Couvelard, 2013, European journal of gastroenterology & hepatology.

New treatment options with cytotoxic agents in neuroendocrine tumours

E. Raymond, S. Faivre, P. Ruszniewski, 2012, Targeted Oncology.

Sunitinib in pancreatic neuroendocrine tumors

E. Raymond, S. Faivre, P. Ruszniewski, 2012, Targeted Oncology.

Prevalence of Extrapancreatic Cancers in Patients With Histologically Proven Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Case–Control Study

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2008, The American Journal of Gastroenterology.

Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation

F. Durand, P. Ruszniewski, V. Rebours, 2015, United European gastroenterology journal.

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.

S. Richard, A. Sauvanet, P. Ruszniewski, 2015, Annals of surgery.

Smoking and the Course of Recurrent Acute and Chronic Alcoholic Pancreatitis: A Dose-Dependent Relationship

P. Ruszniewski, V. Rebours, P. Lévy, 2012, Pancreas.

Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine Tumors

E. Raymond, S. Faivre, P. Ruszniewski, 2009, Neuroendocrinology.

Chemotherapy for Gastro-Enteropancreatic Endocrine Tumours

P. Ruszniewski, O. Hentic, O. Corcos, 2004, Neuroendocrinology.

High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy.

P. Fenaux, P. Ruszniewski, V. Rebours, 2016, Endocrine-related cancer.

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms

A. Cazes, G. Zalcman, P. Ruszniewski, 2021, Cancers.

Recurrence after surgical resection of gastrinoma: who, when, where and why?

A. Sauvanet, J. Belghiti, P. Ruszniewski, 2012, European journal of gastroenterology & hepatology.

Extrahepatic Portal Venous System Thrombosis in Recurrent Acute and Chronic Alcoholic Pancreatitis Is Caused by Local Inflammation and Not Thrombophilia

D. Vidaud, P. Ruszniewski, V. Rebours, 2012, The American Journal of Gastroenterology.

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.

A. Lièvre, M. Ducreux, C. Lepage, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery

P. Ruszniewski, R. Kianmanesh, M. Vullierme, 2015, Neuroendocrinology.

Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours

A. Lièvre, E. Baudin, A. Couvelard, 2019, Neuroendocrinology.

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

E. Baudin, C. Lepage, P. Rougier, 2017, European journal of cancer.

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.

A. Lièvre, C. Lepage, J. Scoazec, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Diagnosis and management of pancreatic fistulae resulting in pancreatic ascites or pleural effusions in the era of helical CT and magnetic resonance imaging.

V. Vilgrain, A. Sauvanet, J. Belghiti, 2007, Gastroenterologie clinique et biologique.

Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut‐like profile

M. Ronot, V. Paradis, A. Sauvanet, 2022, The Journal of pathology.

Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location.

M. Ronot, V. Vilgrain, P. Ruszniewski, 2017, European journal of radiology.

The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment.

M. Ronot, V. Vilgrain, P. Ruszniewski, 2023, Radiology. Imaging cancer.

Granular cell tumor of the pancreas.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2005, Pancreas.

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms

P. Ruszniewski, O. Bouché, A. Couvelard, 2017, Neuroendocrinology.

[Are the causes similar for benign and severe forms of acute pancreatitis?].

P. Ruszniewski, P. Lévy, O. Hentic, 2003, Gastroenterologie clinique et biologique.

Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas

P. Ruszniewski, P. Lévy, O. Hentic, 2006, The American Journal of Gastroenterology.

Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?

P. Bedossa, A. Sauvanet, P. Ruszniewski, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Critical appraisal of MGMT in digestive NET treated with alkylating agents.

V. Paradis, P. Ruszniewski, A. Couvelard, 2020, Endocrine-related cancer.

Fatal Bile Duct Necrosis: A Rare Complication of Transcatheter Arterial Chemoembolization in a Patient with Endocrine Hepatic Metastasis

P. Bedossa, P. Ruszniewski, V. Rebours, 2008, Case Reports in Gastroenterology.

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors.

P. Ruszniewski, A. Couvelard, O. Hentic, 2019, Best practice & research. Clinical endocrinology & metabolism.

Clinical Outcome After a Totally Implantable Venous Access Port-Related Infection in Cancer Patients: A Prospective Study and Review of the Literature

D. Lebeaux, C. Dreyer, B. Fantin, 2012, Medicine.

Endoscopic diagnosis and treatment of neuroendocrine tumors

F. Prat, P. Ruszniewski, O. Hentic, 2021 .

Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2011, The American Journal of Gastroenterology.

The natural history of hereditary pancreatitis: a national series

P. Ruszniewski, M. Boutron‐Ruault, V. Rebours, 2008, Gut.

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors

P. Ruszniewski, M. Perrier, V. Rebours, 2022, Journal of neuroendocrinology.

Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma.

V. Rebours, P. Lévy, O. Hentic, 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

C. Lombard-Bohas, P. Ruszniewski, V. Rebours, 2019, Neuroendocrinology.

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

C. Lombard-Bohas, P. Ruszniewski, V. Rebours, 2019, Neuroendocrinology.

The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study

A. Sauvanet, O. Hentic, J. Cros, 2021, Surgical Endoscopy.

How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort

J. Vaillant, A. Sauvanet, O. Hentic, 2018, Annals of Surgical Oncology.

FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.

E. Raymond, P. Ruszniewski, F. Bonnetain, 2012, World journal of gastroenterology.

Gemcitabine in elderly patients with advanced pancreatic cancer.

E. Raymond, P. Ruszniewski, C. Dreyer, 2011, World journal of gastroenterology.

Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective

P. Ruszniewski, V. Rebours, P. Lévy, 2019, United European gastroenterology journal.

Liver transarterial embolizations in metastatic neuroendocrine tumors

V. Vilgrain, P. Ruszniewski, O. Hentic, 2017, Reviews in Endocrine and Metabolic Disorders.

Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation

P. Ruszniewski, A. Couvelard, V. Rebours, 2017, Neuroendocrinology.

Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging

Jérôme Cros, M. Ronot, V. Vilgrain, 2017, European Radiology.

Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib

M. Ronot, V. Vilgrain, E. Raymond, 2012, Targeted Oncology.

Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.

Pierre Bedossa, V. Vilgrain, P. Bedossa, 2009, Radiology.

Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors

G. Baron, P. Ravaud, V. Paradis, 2009, Modern Pathology.

Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.

C. Tournigand, O. Hentic, A. de Gramont, 2015, Bulletin du cancer.

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort

P. Innominato, O. Hentic, J. Blanc, 2015, Annals of Surgical Oncology.

Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.

I. Sobhani, A. Lièvre, C. Lepage, 2023, The Lancet. Oncology.

Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis.

P. Bedossa, P. Ruszniewski, A. Couvelard, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pancreas; Endocrine Tumors

P. Ruszniewski, O. Hentic, L. Mestier, 2019 .

Contribution of Immune-Mediated Paraneoplastic Syndromes to Neurological Manifestations of Neuroendocrine Tumours: A Retrospective Study

I. Sobhani, P. Ruszniewski, O. Hentic, 2020, Neuroendocrinology.

Metachronous Hormonal Syndromes in Patients With Pancreatic Neuroendocrine Tumors

C. Lombard-Bohas, P. Ruszniewski, A. Couvelard, 2015, Annals of Internal Medicine.

Acute Pancreatitis in Patients Operated on for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Frequency, Severity, and Clinicopathologic Correlations

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2010, Pancreas.

Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors.

M. Perrier, O. Hentic, L. de Mestier, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: a GTE study.

B. Goichot, F. Savagner, O. Hentic, 2020, The Journal of clinical endocrinology and metabolism.

Mucinous Cystic Neoplasms of the Pancreas: Definition of Preoperative Imaging Criteria for High-Risk Lesions

A. Sauvanet, P. Ruszniewski, A. Couvelard, 2011, Pancreatology.

Laparoscopic‐assisted liver transplantation: A realistic perspective

M. Ronot, V. Paradis, V. Vilgrain, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens

V. Rebours, P. Lévy, O. Hentic, 2023, Therapeutic advances in medical oncology.

Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study

Jin‐Young Jang, C. Moulton, M. Falconi, 2020, Frontiers in Medicine.

Phase II study of first-line FOLFIRI for progressive metastatic well-differentiated pancreatic endocrine carcinoma.

F. Bonnetain, O. Hentic, B. Landi, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?

M. Ronot, V. Vilgrain, P. Ruszniewski, 2017, Endocrine connections.

Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin

V. Paradis, P. Ruszniewski, A. Couvelard, 2022, Modern Pathology.

Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome

M. Ronot, V. Vilgrain, A. Sauvanet, 2021, European Radiology.

Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut

E. Baudin, O. Hentic, F. Montravers, 2022, Medicine.

Carcinoid heart disease in patients with midgut neuroendocrine tumours

B. Iung, C. Lombard-Bohas, P. Ruszniewski, 2023, Journal of neuroendocrinology.

Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms

M. Ronot, P. Ruszniewski, A. Couvelard, 2023, Therapeutic advances in medical oncology.